hilar cholangiocarcinoma
Conditions
Interventions
1:Regional resection of hilar cholangiocarcinoma (8a/p, 12a/b/c/h/p, 13a).
2:Hilar cholangiocarcinoma resection and extended lymph node dissection (8a/p, 9,12a/b/c/h/p, 13a, 14, 16).
Sponsors
Renji Hospital Affiliated to Medical School, Shanghai Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) patients aged 18 to 80 years old; 2) diagnosis of hilar cholangiocarcinoma (imaging, laboratory examination, intraoperative frozen, postoperative pathological diagnosis of cholangiocarcinoma; 3) the tumor can be removed completely; 4) the patient is autonomous, understands and voluntarily signs written informed consent and is able to complete the follow-up plan; 5) pregnant women should be excluded from pregnancy; 6) Child-Turcotte-Pugh score of liver function A-B, the upper limit of serum bilirubin = normal value is 1.5 times and the upper limit of alt AST = normal value is 2 times; Anhydride clearance = 60ml / min, hemoglobin = 90g / L; ASA 1-4; 7) sign written informed consent before screening.
Exclusion criteria
Exclusion criteria: 1) resection of tumor R1; 2) the patients had significant heart, lung, brain and renal dysfunction affecting the management of cholangiocarcinoma; 3) the patient has other malignant tumor history; 4) Child-Turcotte-Pugh grade C of liver function; 5) Women who are pregnant or are breastfeeding; 6) the researcher decided that he was not fit to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival; | — |
Countries
China
Contacts
Public ContactJian Wang
Renji Hospital Affiliated to Medical School, Shanghai Jiaotong University
Outcome results
None listed